Pixelworks (NASDAQ:PXLW) was gaining on Friday after beating analysts’ expectations for earnings in the first quarter. For the first quarter Pixelworks reported a loss of -4 cents a share, beating the Capital IQ Consensus Estimate of -7 cents a share by 3 cents. Revenue grew 63.2% from the year-ago quarter to $13.5 million. Analysts expected revenue of $13.1 million for the quarter. Pixelworks, Inc. (NASDAQ:PXLW) net profit margin is -18.50% and weekly performance is 3.52%. On last trading day company shares ended up $5.29. Analysts mean target price for the company is $10.00. Pixelworks, Inc. (NASDAQ:PXLW) distance from 50-day simple moving average (SMA50) is -5.12%.
Universal Display Corporation (NASDAQ:OLED), enabling energy-efficient displays and lighting with its UniversalPHOLED® technology and materials, on 8 may reported financial results for the first quarter ended March 31, 2014. Universal Display Corporation (NASDAQ:OLED) shares advanced 15.20% in last trading session and ended the day on $28.65. OLED gross Margin is 80.30% and its return on assets is 18.20%.Universal Display Corporation (NASDAQ:OLED) quarterly performance is -9.76%.
Rigel Pharmaceuticals (NASDAQ:RIGL) posted its quarterly earnings results on Wednesday. The company reported ($0.25) earnings per share for the quarter, meeting the analysts’ consensus estimate of ($0.25), American Banking & Market News reports. During the same quarter last year, the company posted ($0.29) earnings per share. Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) shares moved up 5.93% in last trading session and was closed at $2.86, while trading in range of $2.64 – $2.89. Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) year to date (YTD) performance is 0.35%.
On May 1, 2014, Celldex Therapeutics, Inc. (NASDAQ:CLDX) issued a press release announcing its financial results for the first quarter of 2014. Celldex Therapeutics, Inc. (NASDAQ:CLDX) ended the last trading day at $12.79. Company weekly volatility is calculated as 11.49% and price to cash ratio as 3.77.Celldex Therapeutics, Inc. (NASDAQ:CLDX) showed a negative weekly performance of -11.85%.